629 Evaluation of provider preferences in first-line metastatic renal cell carcinoma: comparison between dual immunotherapy vs. immunotherapy/tyrosine kinase inhibitors

• Theodore Karrison,
• Priyanka Chablani,
• Walter Stadler

Affiliations

Theodore Karrison

Aff3 grid.170205.10000000419367822Department of Health StudiesUniversity of Chicago Chicago IL USA

Priyanka Chablani

University of Chicago Medical Center, Chicago, IL, United States

Walter Stadler

University of Chicago Medical Center, Chicago, IL, United States